It can be concluded that CerK is a novel regulator of adipogenesis, an action that may have potential implications in the development of obesity, and that targeting this kinase may be beneficial for treatment of obesity-associated diseases. Here, CERK is linked to obesity due to melanocortin 4 receptor deficiency.